Siddharth Mehra, Ph.D.

Postdoc
UM, United States

Presentation(s):

• P32: JNK inhibition reprograms the tumor-immune-microenvironment to overcome chemoresistance in PDAC

  Friday, March 22, 2024
  11:43am – 11:49am ET

• 56: Disrupting TNFR2 Signaling Improves Chemotherapy sensitivity in Pancreatic Cancer

  Saturday, March 23, 2024
  9:02am – 9:12am ET